Skip to content
Merito
← Back to results
EB-2 NIWHealthcare, clinicalIndividualDecided May 2024Dismissed

Outcome: Dismissed

MAY022024_07B5203

Merit and national importanceNot metWell positionedNot reached / not discussedBalance favors a waiverNot reached / not discussed

Our summary

A pharmaceutical chemist self-petitioner sought EB-2 national interest waiver for a pharmacotherapeutic monitoring endeavor. The AAO dismissed the appeal, finding substantial merit but no national importance: evidence did not show how the proposed work would extend beyond direct patients to impact the field or have prospective broader implications.

Official PDF

Official PDF ↗

Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.

No criterion in the table was found met in this decision.

What was missing

  • Merit and national importance · Pharmacotherapeutic monitoring program for vaccine-related blood clots lacked evidence of impact beyond individual patients; no broader field implications shown

Criteria

CriterionReadingWhy
Merit and national importanceNot metPharmacotherapeutic monitoring program for vaccine-related blood clots lacked evidence of impact beyond individual patients; no broader field implications shown
Well positionedNot reached / not discussedNot analyzed; first prong failure made further prongs unnecessary
Balance favors a waiverNot reached / not discussedNot analyzed; first prong failure made further prongs unnecessary

A published decision describes one case. It is not legal advice and not a prediction for yours.

Similar decisions

Decisions whose text is closest to this one.